Get 20% Free Customization In This Report

Buy this report from - $3456

Retinoic Acid Market by Mode of Administration (Oral, and External) and by End User (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Pharmaceuticals	LI_184051	Pages: NA	Jul 2018 \| 479 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Retinoic acid is a metabolite of vitamin A (retinol) that mediates the functions of vitamin A required for growth and development. It is a member of family of retinoids, that are compound either derived from vitamin A or are structurally similar to it.

Rise in incidences of cancers as retinoids find an important application in cancer therapeutics drive the market. In addition, retinoic acid is widely used for the treatment of photoaged skin, psoriasis, skin lesions of Kaposis sarcoma, and for cancers of breast and prostate also fuel the market growth. However, isotretinoin; a form of retinoic acid; is highly teratogenic.

As teratogenic drug can disturb the development of an embryo, therefore the use of retinoic acid is strictly controlled. This restrains the market growth. Conversely, increase in research for the cure of cancers and advancements in cancer therapeutics provide ample opportunities for the market growth.

The retinoic acid market is segmented on the basis of mode of administration, end user, and region. Based on mode of administration, the market is categorized into oral retinoids and external retinoids. By end user, it is classified into hospital pharmacy, retail pharmacy, and online pharmacy. By geography, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players operating in the market include LGM Pharma, GF Health Products, Inc., GYMA Laboratories of America, Inc., Genemed Synthesis Inc., IMCoPharma a. s., Chongqing Huabang Pharmacy Co., Ltd., Olon S.p.A., and Sun Pharmaceutical Industries Ltd.

Key Benefits

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
Key players are profiled and their strategies are analyzed thoroughly, which explains the competitive outlook of the global market.
The report offers a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.

Retinoic Acid Market Key Segments:

By Mode of Administration

Oral
External

By End User

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

Chapter: 4 RETINOIC ACID MARKET, BY MODE OF ADMNISTRATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ORAL

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. EXTERNAL

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 RETINOIC ACID MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITAL PHARMACY

5.2.1. Market size and forecast

5.3. RETAIL PHARMACY

5.3.1. Market size and forecast

5.4. ONLINE PHARMACY

5.4.1. Market size and forecast

Chapter: 6 RETINOIC ACID MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Retinoic Acid Market by Mode Of Administration
6.2.5. North America Retinoic Acid Market by End User

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Retinoic Acid Market by Mode Of Administration
6.3.5. Europe Retinoic Acid Market by End User

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Retinoic Acid Market by Mode Of Administration
6.4.5. Asia-Pacific Retinoic Acid Market by End User

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Saudi Arabia market size and forecast
6.5.3.3. South Africa market size and forecast
6.5.3.4. Rest of LAMEA market size and forecast

6.5.4. LAMEA Retinoic Acid Market by Mode Of Administration
6.5.5. LAMEA Retinoic Acid Market by End User

Chapter: 7 COMPANY PROFILES

7.1. LGM PHARMA

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. GF HEALTH PRODUCTS, INC.

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. GYMA LABORATORIES OF AMERICA, INC.

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. GENEMED SYNTHESIS INC.

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. IMCOPHARMA A. S.

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. CHONGQING HUABANG PHARMACY CO., LTD.

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. OLON S.P.A.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. SUN PHARMACEUTICAL INDUSTRIES LTD.

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Retinoic Acid Market by Mode of Administration (Oral, and External) and by End User (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) - Global Opportunity Analysis and Industry Forecast, 2017-2023